In this week’s edition of InnovationRx, In this week’s edition of InnovationRx, we look at the health risks of winter storms, a new Korean weight loss drug billionaire, a biotech using AI for rare diseases, and more.
Last week’s announcement by SCD that it will jointly develop and commercialize a weight-loss pill fueled a rally in the Korean company’s shares.
Daniel Nadler, the 42-year-old CEO and cofounder of OpenEvidence, is now worth $7.6 billion as his AI search tool surges in popularity among U.S. doctors.
A lawsuit filed by electronic health record giant Epic could encourage reforms to a problematic system, where non-health companies can access patient records without their knowledge.
B.Grimm Power—controlled by Thai billionaire Harald Link—has bought a stake in U.S.-based hydropower operator New England Reliable Hydropower Holdings for 7.24 billion baht ($230 million) amid the group’s drive to expand its overseas renewable energy p…
Yan Junjie, the 36-year-old chairman and CEO of MiniMax, now boasts a net worth of $3.2 billion after the AI model developer’s $618 million Hong Kong IPO.
Zhipu, which operates a ChatGPT-like service called Z.ai, raised $558 million in the IPO. Its chairman, Liu Debing, amassed a fortune of $2.1 billion based on his stake in the Chinese AI model company.
From Trump frenemyship, the DOGE debacle, unmet self-driving car promises, chainsaws and “Mechahitler” to a $1 trillion pay deal, 2025 was the billionaire’s most chaotic and lucrative year.
Record activity in the AI sector this year has boosted dozens of founders and business executives into the billionaire ranks.
In this week’s edition of The Prototype, we look at a drug to help spinal injuries, a crypto billionaire’s big space play, revitalizing aging immune systems and more.